Andrew Lytle

7PUBLICATIONS
134CO-AUTHORS
Molecular targetsTumour immunologyHaematological tumoursImmunology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 13, 2026
IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancers.

Hai-Feng Zhang, Edouard De Dreuzy, Yue Zhou Huang

|Apr 25, 2024
TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.

Michael Y Li, Lauren C Chong, Gerben Duns

|Dec 11, 2023
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition.

Alan Cooper, Sravya Tumuluru, Kyle Kissick

|Oct 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.

Leandro Venturutti, Martin A Rivas, Benedikt W Pelzer

|Jun 03, 2022
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.

Min Xia, Liron David, Matt Teater

Pageof 2